The Trump administration has paused the Federal Trade Commission’s lawsuit against major pharmacy benefit managers after two Democratic commissioners were fired earlier this month. The lawsuit, originally filed last year under the Biden administration, was considered a major challenge to the PBM industry after the agency accused the drug middlemen of inflating the price of insulin and driving up costs to diabetes patients. The FTC issued the stay in the case against CVS Caremark, OptumRx and Express Scripts in response to a motion “citing the fact that there are currently no sitting Commissioners able to participate in this matter.”
Read the full article: FTC Halts Case Against CVS Caremark, OptumRx //
Source: https://www.axios.com/2025/04/03/ftc-stays-case-cvs-caremark-optumrx-pbm